参考文献/References:
[1]窦家庆,唐松涛,杨启程,等.2型糖尿病患者的血管并发症与血糖控制及其危险因素的相互关系[J].安徽医科大学学报,2017,52(3):426-430.[2]万仁辉,鲁瑾.2型糖尿病大血管并发症的影响因素[J].第二军医大学学报,2020,41(1):75-80.[3]郑梦伊,赵权辉,刘盈池,等.开滦研究年龄≤50岁人群早期血管衰老检出率及影响因素[J].中华高血压杂志,2020,28(4):355-361.[4]Lacolley P,Regnault V,Avolio AP.Smooth muscle cell and arterial aging: basic and clinical aspects[J].Cardiovasc Res,2018,114(4):513-528.[5]Lin X,Zhan JK,Zhong JY,et al.lncRNA-ES3/miR-34c-5p/BMF axis is involved in regulating high-glucose-induced calcification/senescence of VSMCs[J].Aging(Albany NY),2019,11(2):523-535.[6]Poetsch F,Henze LA,Estepa M,et al.Role of SGK1 in the Osteogenic Transdifferentiation and Calcification of Vascular Smooth Muscle Cells Promoted by Hyperglycemic Conditions[J].Int Mol Sci,2020,21(19):7207.[7]王景尚,黄烨,陈可冀,等.2型糖尿病患者血糖波动状态与血管内皮损伤、血小板活化及PKCβ1表达的相关性[J].中国中西医结合杂志,2016,36(10):1184-1190.[8]Alizadeh S,Mirshafiey A,Djalali M,et al.Vitamin D3 Induces Gene Expression of Ox-LDL Scavenger Receptors in Streptozotocin-Induced Diabetic Rat Aortas: New Insight into the Role of Vitamin D in Diabetic Atherosclerosis[J].Rep Biochem Mol Biol,2018,6(2):170-177.[9]Luo Y,Lu S,Dong X,et al.Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway[J].Apoptosis,2017,22(8):1013-1024.[10]Durham AL,Speer MY,Scatena M,et al.Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness[J].Cardiovasc Res,2018,114(4):590-600.[11]Ito F,Ito T,Suzuki C,et al.The Application of a Modified d-ROMs Test for Measurement of Oxidative Stress and Oxidized High-Density Lipoprotein[J].Int J Mol Sci,2017,18(2):454.[12]丁存涛,周亚群,孙希鹏,等.糖脂代谢对原发性高血压病人血管内皮功能的影响[J].首都医科大学学报,2017,38(3):401-405.[13]阚春婷,曹长春.糖尿病、冠心病患者Metrnl水平与糖脂代谢指标和部分炎性标志物水平的关系[J].国际检验医学杂志,2021,42(17):2113-2117.[14]Poznyak A,Grechko AV,Poggio P,et al.The Diabetes Mellitus-Atherosclerosis Connection:The Role of Lipid and Glucose Metabolism and Chronic Inflammation[J].Int J Mol Sci,2020,21(5):1835.[15]Bhardwaj R,Singh BP,Sandhu N,et al.Probiotic mediated NF-κB regulation for prospective management of type 2 diabetes[J].Mol Biol Rep,2020,47(3):2301-2313.[16]蔺昕燕,贾玉红,郭连英,等.p53-p21通路在动脉血管平滑肌细胞衰老中的作用研究[J].大连医科大学学报,2015,37(4):339-344.[17]Huang D,Gao W,Zhong X,et al.NLRP3 activation in endothelia promotes development of diabetes-associated atherosclerosis[J].Aging(Albany NY),2020,12(18):18181-18191.[18]Jin H,Zhu Y,Wang XD,et al.BDNF corrects NLRP3 inflammasome-induced pyroptosis and glucose metabolism reprogramming through KLF2/HK1 pathway in vascular endothelial cells[J].Cell Signal,2021,78:109843.[19]Yin Y,Zhou Z,Liu W,et al.Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway[J].Int J Biochem Cell Biol,2017,84:22-34.[20]Bubb KJ,Drummond GR,Figtree GA.New opportunities for targeting redox dysregulation in cardiovascular disease[J].Cardiovasc Res,2020,116(3):532-544.[21]于博文,王雪,胡艳红,等.内皮微粒对血管内皮细胞衰老的影响及机制研究[J].中国病理生理杂志,2021,37(5):825-833.[22]Login CC,Baldea I,Tiperciuc B,et al.A Novel Thiazolyl Schiff Base: Antibacterial and Antifungal Effects and In Vitro Oxidative Stress Modulation on Human Endothelial Cells[J].Oxid Med Cell Longev,2019,2019:1607903.[23]Hansen M,Rubinsztein DC,Walker DW.Publisher Correction: Autophagy as a promoter of longevity:insights from model organisms[J].Nat Rev Mol Cell Biol,2018,19(9):611.[24]Aragonès G,Dasuri K,Olukorede O,et alAutophagic receptor p62 protects against glycation‐derived toxicity and enhances viability[J].Aging Cell,2020,19(11):e13257.[25]Zhang F,Gao F,Wang K,et al.MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway[J].Stem Cell Res Ther,2021,12(1):115.[26]Aki T,Unuma K,Noritake K,et al.Formation of high molecular weight p62 by CORM-3[J].PLoS One,2019,14(1):e0210474.[27]周建华,李晓华,贝鹏剑,等.早期2型糖尿病肾病患者血糖波动与氧化应激、炎症及单核细胞自噬的相关性[J].中国老年学杂志,2021,41(1):32-36.[28]毛琦,邓梦杨,李禄丰,等.Klotho激活自噬对氧化低密度脂蛋白介导的人冠状动脉内皮细胞衰老的影响[J].解放军医学杂志,2020,45(6):587-595.[29]孙丹,杨爽,王力宁,等.高糖通过抑制自噬活性和激活p53/p21信号通路促进人肾小球系膜细胞衰老[J].中华肾脏病杂志,2016,32(9):685-690.[30]Zhang Y,Cross SD,Stanton JB,et al.Early AMD-like defects in the RPE and retinal degeneration in aged mice with RPE-specific deletion of Atg5 or Atg7[J].Mol Vis,2017,23:228-241.[31]Phadwal K,Feng D,Zhu D,et al.Autophagy as a novel therapeutic target in vascular calcification[J].Pharmacol Ther,2020,206:107430.[32]Wang X,Khalil RA.Matrix Metalloproteinases,Vascular Remodeling,and Vascular Disease[J].Adv Pharmacol,2018,81:241-330.[33]郭春玲,逯朝阳,杨滨,等.血管紧张素(1-7)通过p53/Drp1轴对血管紧张素Ⅱ诱导的血管内皮细胞衰老的影响[J].中国动脉硬化杂志,2020,28(11):960-965.[34]廉亚茹,刘新华,韩苗,等.p38-p53-p21信号通路参与调控血管紧张素-Ⅱ诱导的人血管平滑肌细胞衰老[J].复旦学报(自然科学版),2015,54(6):768-777,785.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(11):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Medical Information,2018,31(11):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Medical Information,2018,31(11):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(11):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Medical Information,2018,31(11):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2022,35(11):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Medical Information,2022,35(11):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Medical Information,2022,35(11):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Medical Information,2018,31(11):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[10]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Medical Information,2018,31(11):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]